UC Davis researchers discover target molecule to repair injured nerve cells

June 21, 2011

A team of investigators at UC Davis and Shriners Hospital have discovered that a factor in the embryonic development of brain cells is an important target for developing new drugs and stem cell therapies to treat patients who have lost function from multiple sclerosis, cerebral palsy, stroke and other “demyelinating” diseases.  (Media Newswire)